Kiniksa Pharmaceuticals International Plc (KNSA) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Kiniksa Pharmaceuticals International Plc  (NASDAQ: KNSA)
 

Kiniksa Pharmaceuticals International Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Kiniksa Pharmaceuticals International Plc's inventory turnover ratio sequentially decreased to 1.48 in the first quarter 2026, unsurprisingly, as the Kiniksa Pharmaceuticals International Plc markets continue to deteriorate, and KNSA's faces growing challenges to bring down its inventories. Kiniksa Pharmaceuticals International Plc's average inventory processing period in the Mar 31 2026 quarter, has increased to 247 days, from 195 days, in the Dec 31 2025 quarter.

Within Healthcare sector 262 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 442, from total ranking in the fourth quarter 2025 at 1289.

KNSA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Kiniksa Pharmaceuticals International Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KNSA Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 231.42 % 108.22 % 44.34 % 38.22 % -19.1 %
Y / Y Cost of Sales Growth 16.39 % 17.04 % 0.74 % 50.97 % 68.84 %
Inventory Turnover Ratio (TTM) 1.48 1.87 2.16 2.38 2.44
KNSA's Total Ranking # 442 # 1289 # 540 # 540 # 1196
Average inventory processing period 246 196 169 154 150
Seq. Inventory Growth 33.24 % 32.61 % -14.08 % 118.32 % -16.29 %
Seq. Cost of Sales Growth -0.71 % 3.4 % 8.89 % 4.11 % -0.16 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 71
Healthcare Sector # 263
Overall Market # 442

Inventory Turnover Ratio Statistics
High Average Low
2.44 1.69 1.28
(Mar 31 2025)   (Dec 31 2023)



KNSA Company Profile >> Back to KNSA Efficiency Comparisons >> Compare KNSA Inventory Turnover Ratio to its Competitors

Financial Statements
Kiniksa Pharmaceuticals International Plc's Inventories $ 73 Millions Visit KNSA's Balance sheet
Kiniksa Pharmaceuticals International Plc's Cost of Revenues TTM $ 81 Millions Visit KNSA's Income Statement
What are KNSA's Sales? Visit KNSA's Sales by Segment

Other Inventory Turnover Ratios
Kiniksa Pharmaceuticals International Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
KNSA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for KNSA's Competitors
Inventory Turnover Ratio for KNSA's Suppliers
Inventory Turnover Ratio for KNSA's Customers

You may also want to know
KNSA's Sales Growth Rates KNSA's Pe Price to earnings ratio KNSA's Receivables Turnover Ratio KNSA's Stock Quote
KNSA's Net Income Growth Rates KNSA's Ps Price to Sales ratio KNSA's Sales per Employee KNSA's Asset Turnover Ratio
KNSA's Net Margin KNSA's Pb Price to Book ratio KNSA's Financial Strength Ratios KNSA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Indivior Pharmaceuticals Inc   3.03 $ 242.000  Millions$ 80  Millions
Amneal Pharmaceuticals Inc   3.02 $ 1,868.000  Millions$ 618  Millions
Logicmark Inc  3.01 $ 3.826  Millions$ 1  Millions
Mettler toledo International Inc   3.01 $ 1,189.678  Millions$ 395  Millions
Revvity Inc  3.00 $ 1,151.379  Millions$ 384  Millions
Cannapharmarx Inc   2.98 $ 2.921  Millions$ 1  Millions
Becton Dickinson And Company  2.97 $ 11,368.000  Millions$ 3,821  Millions
Dexcom Inc   2.97 $ 1,854.000  Millions$ 624  Millions
Msa Safety Inc  2.93 $ 1,020.000  Millions$ 349  Millions
Nexgel Inc   2.92 $ 6.000  Millions$ 2  Millions
Abbott Laboratories  2.91 $ 19,741.000  Millions$ 6,785  Millions
Zai Lab Limited  2.91 $ 128.112  Millions$ 44  Millions
Mimedx Group Inc   2.87 $ 74.000  Millions$ 26  Millions
Dentsply Sirona Inc   2.82 $ 1,880.000  Millions$ 666  Millions
Catalyst Pharmaceuticals Inc   2.82 $ 83.817  Millions$ 30  Millions
Evofem Biosciences Inc   2.82 $ 4.662  Millions$ 2  Millions
Livanova Plc  2.80 $ 464.684  Millions$ 166  Millions
Orthofix Medical Inc   2.79 $ 242.580  Millions$ 87  Millions
Lifecore Biomedical Inc   2.76 $ 89.000  Millions$ 32  Millions
Zeo Scientifix Inc   2.76 $ 1.291  Millions$ 0  Millions
Akebia Therapeutics Inc   2.76 $ 44.127  Millions$ 16  Millions
Biomerica Inc   2.72 $ 4.142  Millions$ 2  Millions
Nephros Inc   2.71 $ 8.000  Millions$ 3  Millions
Neogen Corporation  2.70 $ 478.000  Millions$ 177  Millions
Merck and Co Inc   2.62 $ 17,158.000  Millions$ 6,546  Millions
Ligand Pharmaceuticals Incorporated  2.62 $ 32.548  Millions$ 12  Millions
Electrocore Inc   2.57 $ 4.012  Millions$ 2  Millions
Anika Therapeutics Inc   2.57 $ 48.000  Millions$ 19  Millions
Illumina Inc   2.54 $ 1,485.000  Millions$ 585  Millions
Ani Pharmaceuticals Inc  2.53 $ 361.855  Millions$ 143  Millions

Date modified: 2026-06-22T16:30:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.